Biocon Ltd - ESG Rating & Company Profile powered by AI
Other companies in the rating peer group for Biocon Ltd are shown. This webpage of Biocon Ltd was assembled by All Street Sevva using advanced AI. This webpage includes a Q&A table on Biocon Ltd.
Biocon Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Biocon Ltd | 8.0 | High |
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Biocon Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Biocon Ltd disclose current and historical energy intensity?
Does Biocon Ltd report the average age of the workforce?
Does Biocon Ltd reference operational or capital allocation in relation to climate change?
Does Biocon Ltd disclose its ethnicity pay gap?
Does Biocon Ltd disclose cybersecurity risks?
Does Biocon Ltd offer flexible work?
Does Biocon Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Biocon Ltd disclose the number of employees in R&D functions?
Does Biocon Ltd conduct supply chain audits?
Does Biocon Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Biocon Ltd conduct 360 degree staff reviews?
Does Biocon Ltd disclose the individual responsible for D&I?
Does Biocon Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Biocon Ltd disclose current and / or historical scope 2 emissions?
Does Biocon Ltd disclose water use targets?
Does Biocon Ltd have careers partnerships with academic institutions?
Did Biocon Ltd have a product recall in the last two years?
Does Biocon Ltd disclose incidents of discrimination?
Does Biocon Ltd allow for Work Councils/Collective Agreements to be formed?
Has Biocon Ltd issued a profit warning in the past 24 months?
Does Biocon Ltd disclose parental leave metrics?
Does Biocon Ltd disclose climate scenario or pathway analysis?
Does Biocon Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Biocon Ltd disclose the pay ratio of women to men?
Does Biocon Ltd support suppliers with sustainability related research and development?
Does Biocon Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Biocon Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Biocon Ltd involved in embryonic stem cell research?
Does Biocon Ltd disclose GHG and Air Emissions intensity?
Does Biocon Ltd disclose its waste policy?
Does Biocon Ltd report according to TCFD requirements?
Does Biocon Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Biocon Ltd disclose energy use targets?
Does Biocon Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Biocon Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Biocon Ltd
These potential risks are based on the size, segment and geographies of the company.
Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Small Molecules, Biologics, Branded Formulations, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, dermatology, ophthalmology, neurology, rheumatology, and inflammatory diseases. The company provides biosimilars comprising recombinant human insulin, insulin glargine, biosimilar trastuzumab, and other biopharmaceuticals; small molecules, such as active pharmaceutical ingredients and generic formulations; and branded formulation products under the Insugen, Basalog, BIOMAb EGFR, CANMAb, and ALZUMAb brands. It is also involved in the integrated discovery, development, and manufacturing services for small and large molecules, antibody-drug conjugates, and oligonucleotides. The company serves customers in approximately 120 countries. Biocon Limited was founded in 1978 and is headquartered in Bengaluru, India.